期刊文献+

间歇性高糖环境对小鼠颅骨成骨细胞的影响 被引量:2

下载PDF
导出
摘要 目的:观察间歇性高糖环境对小鼠颅骨成骨细胞形态、增殖及功能蛋白表达的影响。方法:将体外培养原代小鼠颅骨成骨细胞分为3组:正常糖浓度组(5.5mmol/L GLU)、持续性高糖组(25mmol/L GLU)、间歇性高糖组(5.5mmol/L GLU^25mmol/L GLU),干预3天后,MTT法检测细胞增殖抑制率;干预3周后,比色法和放射免疫法(RIA)分别检测培养上清液中碱性磷酸酶(ALP)和骨钙素(OCN)水平的变化。结果:(1)在相同干预时间点,与正常糖浓度组相比,高糖组细胞增殖受抑制,其中间歇性高糖组细胞受抑制更显著(P<0.05)。(2)在相同干预时间点,高糖组成骨细胞的ALP、OCN均较正常糖浓度组下降,其中间歇性高糖组下降更显著;(3)随干预时间增加,高糖组成骨细胞的ALP、OCN均较正常糖浓度组下降(P<0.05)。结论:高糖环境可抑制成骨细胞的增殖、诱发细胞凋亡,并导致功能蛋白ALP、OCN下降,且这一损害作用在间歇性高糖环境更为显著。
出处 《海峡科学》 2014年第2期8-10,共3页 Straits Science
基金 福建省教育厅基金(JA10156)
  • 相关文献

参考文献7

  • 1Lipscombe LL, Jarnal SA, Booth GL, Hawker GA. The risk of hip fractures in older.individuals with diabetes: a populationbased study[J]. Diabetes Care, 2007, 30(4): 835-841.
  • 2Hamann C, Goettseh C, Mettelsiefen J, Henkenjohann V, Rauner M, Hempel U, Bernhardt R, Fratzl-Zelman N, Roschger P, Rammelt S, G/inther KP, Hofbauer LC. Delayed bone regeneration and low bone mass in a rat model ol insulin-resistant type 2 diabetes mellitus is due to impaired osteobl ast function[J]. Am J Physiol Endocrinol Metab, 2011,301(6):E1220-1228.
  • 3严孙杰,李毅敏,沈喜妹,颜晓芳.二甲双胍对小鼠颅骨成骨细胞糖毒性损害的保护作用[J].中国新药与临床杂志,2011,30(11):852-856. 被引量:2
  • 4Zhou B, Li H, Xu L, Zang W, Wu S, Sun H. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-r,B signaling pathway[J]. Endocrinology, 2013, 154(3):1055-1068.
  • 5Wang Q, Zhang B, Xu Y, Xu H, Zhang N. The Relationship between Serum Osteocalein Concentration and Glucose Metabolism in Patients with Type 2 Diabetes Mellitus. Int J Endocrinol, 2013: 842598.
  • 6Bull6 M, Moreno-Navarrete JM, Femindez-Real JM, Salas-Salvado J. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and 13 cell function in elderly men at high cardiovascular risk[J]. Am J Clin Nutr, 2012, 95(1):249-255.
  • 7Ogawa-Furuya N, Yamaguchi T, Yamamoto M, Kanazawa l, Sugimoto T. Serum osteocalcin levels are inversely associated with abdominal aortic calcification in men with type 2 diabetes mellitus. Osteoporos Int, 2013.

二级参考文献10

  • 1GOLDSTEIN BJ. Cliniacal translation of “a diabetes outcome procession trail": ADOPTappropriate combination oral therapies in type 2 diabetes[J]. J Clin Endocrinol Metab, 2007, 92(4): 1226-1228.
  • 2SCHWARTZ AV, SELLMEYER DE, VITYINGHOFF E, et al. Thiazolidinedione use and bone loss in older diabetic aduhs[J]. J Clin Endocrinol Metab, 2006, 91 (9) : 3349-3354.
  • 3VESTERGAARD P, REJNMARK L, MOSEKILDE L. Relative fracture risk in patients with diabetes meUitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk [J]. Diabetologia, 2005, 48(7) : 1292-1299.
  • 4LIPSCOMBE LL, JAMAL SA, BOOTH GL, et al. The risk of hip fractures in older individuals with diabetes: a population- based study[J]. Diabetes Care, 2007, 30(4) : 835-841.
  • 5BIERHAUS A, HOFMANN MA, ZIEGLER R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus: I. The AGE concept[J]. Cardiovasc Res, 1998, 37(3): 586-600.
  • 6ROSEN CJ, BOUXSEIN ML. Mechanisms of disease: is osteo- prosis the obesity of bone?[J]. Nat Clin Pract Rheumatol, 2006, 2(1): 34-43.
  • 7CORTIZO AM, SEDLINSKY C, McCARTHY AD, et al. Osteo- genic actions of the anti-diabetic drug metformin on osteoblasts in culture[J]. Eur J Pharmacol, 2006, 536(1-2): 38-46.
  • 8LAZARENKO OP, RZONCA SO, SUVA LJ, et ol. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat [J]. Bone, 2006, 38 (1) : 74-84.
  • 9KANAZAWA I, YAMAGUCHI T, YANO S, et al. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 ceils via AMP kinase activation as well as eNOS and BMP-2 expression[J]. Biochem Biophys Res Commun, 2008, 375(3) : 414-419.
  • 10李美蓉,林经安,严孙杰.高糖环境中吡格列酮对MC3T3-E1成骨细胞的作用及其机制[J].中国新药与临床杂志,2011,30(1):24-29. 被引量:4

共引文献1

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部